CD8+ tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis

被引:123
作者
Radoja, S
Saio, M
Schaer, D
Koneru, M
Vukmanovic, S
Frey, AB
机构
[1] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
关键词
D O I
10.4049/jimmunol.167.9.5042
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-infiltrating lymphocytes (TIL) are well known to be functionally impaired typified by the inability to lyse cognate tumor cells in vitro. We have investigated the basis for defective TIL lytic function in transplantable murine tumor models. CD8(+) TIL are nonlytic immediately on isolation even though they express surface activation markers, contain effector phase cytokine mRNAs, and contain perforin and granzyme B proteins which are packaged into lytic granules. Ag-specific lytic capability is rapidly recovered if purified TIL are briefly cultured in vitro and tumor lysis is perforin-, but not Fas ligand mediated. In response to TCR ligation of nonlytic TIL in vitro, proximal and distal signaling events are normal; calcium flux is rapid; mitogen-activated protein/extracellular signal-related kinase kinase, extracellular regulatory kinase 2, phosphoinositide-3 kinase, and protein kinase C are activated; and IL-2 and IFN-gamma is secreted. However, on conjugate formation between nonlytic TIL and cognate tumor cells in vitro, the microtubule-organizing center (MTOC) does not localize to the immunological synapse, thereby precluding exocytosis of preformed lytic granules and accounting for defective TIL lytic function. Recovery of TCR-mediated, activation-dependent MTOC mobilization and lytic activity requires proteasome function, implying the existence of an inhibitor of MTOC mobilization. Our findings show that the regulated release of TIL cytolytic granules is defective despite functional TCR-mediated signal transduction.
引用
收藏
页码:5042 / 5051
页数:10
相关论文
共 45 条
[1]   MOUSE EMBRYO FIBROBLASTS TRANSFORMED BY ACTIVATED RAS OR DOMINANT-NEGATIVE P53 EXPRESS CROSS-REACTIVE TUMOR REJECTION ANTIGENS [J].
APPLEMAN, LJ ;
UYEKI, J ;
FREY, AB .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (06) :887-894
[2]   Altered effector responses of H-Y transgenic CD8(+) cells [J].
Arsov, I ;
Vukmanovic, S .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (10) :1423-1430
[3]   COMPARATIVE INVITRO SENSITIVITY OF 2 METHYLCHOLANTHRENE-INDUCED MURINE SARCOMA LINES TO HUMORAL AND CELLULAR IMMUNE CYTOTOXICITY [J].
BATAILLON, G ;
PROSS, H ;
KLEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1975, 16 (02) :255-265
[4]   Signal transduction by human NK cell MHC-recognizing receptors [J].
Binstadt, BA ;
Brumbaugh, KM ;
Leibson, PJ .
IMMUNOLOGICAL REVIEWS, 1997, 155 :197-203
[5]  
BLONDEL P, 1998, J IMMUNOL, V161, P2187
[6]   Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes [J].
DePlaen, E ;
Lurquin, C ;
Lethe, B ;
vanderBruggen, P ;
Brichard, V ;
Renauld, JC ;
Coulie, P ;
VanPel, A ;
Boon, T .
METHODS, 1997, 12 (02) :125-142
[7]   Ca2+ signaling modulates cytolytic T lymphocyte effector functions [J].
Esser, MT ;
Haverstick, DM ;
Fuller, CL ;
Gullo, CA ;
Braciale, VL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (07) :1057-1067
[8]   Where have all the T cells gone? Mechanisms of immune evasion by tumors [J].
Finke, J ;
Ferrone, S ;
Frey, A ;
Mufson, A ;
Ochoa, A .
IMMUNOLOGY TODAY, 1999, 20 (04) :158-160
[9]   Negative regulation of Fc epsilon RI-mediated degranulation by CD81 [J].
Fleming, TJ ;
Donnadieu, E ;
Song, CH ;
VanLaethem, F ;
Galli, SJ ;
Kinet, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1307-1314
[10]  
Fuller CL, 1999, J IMMUNOL, V162, P6337